変形性関節症治療法の世界市場予測:解剖学別、薬物種類別、投与経路別、流通チャンネル別

LINEで送る

1 Introduction (Page No. – 17)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2 Research Methodology (Page No. – 20)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Assumptions for the Study
3 Executive Summary (Page No. – 27)
4 Premium Insights (Page No. – 31)
4.1 Osteoarthritis Therapeutics Market Overview
4.2 Europe: Market Share, By Anatomy (2018)
4.3 Geographical Snapshot of the Market
5 Market Overview (Page No. – 34)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rapid Growth in the Geriatric and Obese Populations and the Associated Increase in the Prevalence of Osteoarthritis
5.2.1.2 Increasing Incidence of Sports Injuries
5.2.2 Restraints
5.2.2.1 Risk of Adverse Cardiovascular Events Associated With the Use of Nsaids in Osteoarthritis Treatment
5.2.3 Opportunities
5.2.3.1 Emerging Markets
5.2.3.2 Strategic Collaborations Focused on New Product Development
5.2.4 Challenges
5.2.4.1 Availability of Alternative Non-Drug Pain Management Therapies
6 Osteoarthritis Therapeutics Market, By Anatomy (Page No. – 39)
6.1 Introduction
6.2 Knee Osteoarthritis
6.2.1 Rising Obese and Geriatric Populations to Increase the Prevalence of Knee Osteoarthritis
6.3 Hip Osteoarthritis
6.3.1 Similar to Knee Osteoarthritis, Hip Osteoarthritis is More Common in the Geriatric and Obese Populations
6.4 Hand Osteoarthritis
6.4.1 Rising Prevalence of Shoulder Osteoarthritis to Drive Market Growth
6.5 Small-Joint Osteoarthritis
6.5.1 Rising Number of Ankle-Related Sports Injuries to Increase the Prevalence of Ankle Osteoarthritis
7 Osteoarthritis Therapeutics Market, By Drug Type (Page No. – 45)
7.1 Introduction
7.2 Viscosupplementation Agents
7.2.1 Viscosupplementation Agents Dominated the Market in 2018
7.3 Nonsteroidal Anti-Inflammatory Drugs
7.3.1 Nsaids Can Relieve Pain and Inflammation Without the Various Potential Adverse Effects Associated With Corticosteroids
7.3.1.1 Ibuprofen
7.3.1.2 Diclofenac
7.3.1.3 Aspirin
7.3.1.4 Naproxen
7.3.1.5 Other Molecules
7.4 Analgesics
7.4.1 Acetaminophen
7.4.2 Duloxetine
7.5 Corticosteroids
8 Osteoarthritis Therapeutics Market, By Route of Administration (Page No. – 54)
8.1 Introduction
8.2 Oral Route
8.3 Parenteral Route
8.4 Topical Route
9 Osteoarthritis Therapeutics Market, By Distribution Channel (Page No. – 58)
9.1 Introduction
9.2 Hospital Pharmacies
9.3 Online Pharmacies
9.4 Retail Pharmacies
10 Osteoarthritis Therapeutics Market, By Purchasing Pattern (Page No. – 62)
10.1 Introduction
10.2 Prescription Drugs
10.2.1 Prescription Drugs to Account for A Larger Share of the Market
10.3 Over-The-Counter Drugs
10.3.1 Ease of Purchase and Administration Resulting in A Rising Demand for Otc Drugs
11 Osteoarthritis Therapeutics Market, By Region (Page No. – 65)
11.1 Introduction
11.2 Europe
11.2.1 Italy
11.2.2 Germany
11.2.3 Spain
11.2.4 France
11.2.5 UK
11.2.6 Rest of Europe
11.3 North America
11.3.1 US
11.3.2 Canada
11.4 Asia Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Rest of Asia Pacific
11.5 Rest of the World
12 Competitive Landscape (Page No. – 115)
12.1 Overview
12.2 Market Ranking Analysis, 2018
12.3 Competitive Scenario
12.3.1 Product Launches and Approvals, 2016–2019
12.3.2 Collaborations, 2016–2019
12.3.3 Expansions, 2016–2019
12.3.4 Acquisitions, 2016–2019
12.3.5 Other Developments
12.4 Competitive Leadership Mapping
12.4.1 Vendor Inclusion Criteria
12.4.2 Visionary Leaders
12.4.3 Innovators
12.4.4 Dynamic Differentiators
12.4.5 Emerging Companies
13 Company Profiles (Page No. – 120)
(Business Overview, Products Offered, Recent Developments, MnM View)*
13.1 Sanofi
13.2 Horizon Therapeutics PLC
13.3 Johnson & Johnson
13.4 Glaxosmithkline PLC
13.5 Bayer AG
13.6 Abbott
13.7 Pfizer, Inc.
13.8 Eli Lilly
13.9 Anika Therapeutics, Inc.
13.10 Novartis
13.11 Ferring Pharmaceuticals
13.12 Bioventus
13.13 Zimmer Biomet Holdings, Inc.
13.14 Fidia Farmaceutici S.P.A.
13.15 Flexion Therapeutics, Inc.
*Business Overview, Products Offered, Recent Developments, MnM View Might Not Be Captured in Case of Unlisted Companies.
14 Appendix (Page No. – 141)
14.1 Discussion Guide
14.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
14.3 Available Customizations
14.4 Related Reports
14.5 Author Details




※当サイトのレポート紹介カバレッジ
■産業:医療、IT、電子、自動車、産業機械、建設、消費財、食品、化学、材料、エネルギー、金融、サービスなど多様
■地域:世界市場、アジア市場、中国市場、欧州市場、北米市場、中南米市場、中東市場、アフリカ市場など全世界
■レポート種類:市場動向、規模、占有率、トレンド、将来展望、未来予測、業界分析、産業分析、企業分析、事業機会分析、戦略提言など多様